THE TGA's controversial new list of "permitted indications for listed medicines" has now been implemented, applying to complementary medicines and sunscreens sold in Australia.
Under the reforms, sponsors who apply to list a new medicine will be required to select the indications for their product from the list, with a three year transition period for sponsors of existing listed medicines to re-list their items using permitted indications.
The TGA said the changes provided transparency on what indications were suitable for listed medicines, and "provides greater protection for consumers from misleading and inappropriate claims" - more at www.tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Mar 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Mar 18
